MX2011008497A - Variantes de hemaglutinina y neuraminidasa de influenza. - Google Patents
Variantes de hemaglutinina y neuraminidasa de influenza.Info
- Publication number
- MX2011008497A MX2011008497A MX2011008497A MX2011008497A MX2011008497A MX 2011008497 A MX2011008497 A MX 2011008497A MX 2011008497 A MX2011008497 A MX 2011008497A MX 2011008497 A MX2011008497 A MX 2011008497A MX 2011008497 A MX2011008497 A MX 2011008497A
- Authority
- MX
- Mexico
- Prior art keywords
- influenza hemagglutinin
- neuraminidase variants
- neuraminidase
- variants
- vaccines
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Abstract
Se proporcionan, polipéptidos, polinucleátidos, virus reordenantes, composiciones inmungénicas y vacunas que comprenden variantes de hemaglutinina y neuraminidasa de influenza y el método de uso de los mismos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15209409P | 2009-02-12 | 2009-02-12 | |
PCT/US2010/022970 WO2010093537A2 (en) | 2009-02-12 | 2010-02-03 | Influenza hemagglutinin and neuraminidase variants |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2011008497A true MX2011008497A (es) | 2011-12-16 |
Family
ID=42562246
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2011008497A MX2011008497A (es) | 2009-02-12 | 2010-02-03 | Variantes de hemaglutinina y neuraminidasa de influenza. |
MX2013015094A MX343411B (es) | 2009-02-12 | 2011-08-11 | Variantes de hemaglutinina y neuraminidasa de influenza. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2013015094A MX343411B (es) | 2009-02-12 | 2011-08-11 | Variantes de hemaglutinina y neuraminidasa de influenza. |
Country Status (11)
Country | Link |
---|---|
US (2) | US8613935B2 (es) |
EP (1) | EP2396033B1 (es) |
JP (1) | JP5818693B2 (es) |
CN (1) | CN102361649A (es) |
AU (1) | AU2010213966B2 (es) |
BR (1) | BRPI1008549A2 (es) |
CA (1) | CA2752205A1 (es) |
MX (2) | MX2011008497A (es) |
RU (2) | RU2535970C2 (es) |
SG (2) | SG173642A1 (es) |
WO (1) | WO2010093537A2 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2525672T3 (es) | 2004-05-25 | 2014-12-29 | Medimmune, Llc | Variantes de la hemaglutinina y la neuraminidasa de influenza |
JP2010500034A (ja) | 2006-08-09 | 2010-01-07 | メッドイミューン バクシーンズ,インコーポレイティド | インフルエンザ赤血球凝集素変異体およびノイラミニダーゼ変異体 |
BRPI1008549A2 (pt) | 2009-02-12 | 2016-03-15 | Medimmune Llc | variantes de neuraminidase e hemaglutinina de influenza |
EP2640405A4 (en) | 2010-09-21 | 2015-04-15 | Massachusetts Inst Technology | TREATMENT AND / OR CHARACTERIZATION OF INFLUENZA; POLYPEPTIDES HA ADAPTED TO MAN |
CN108103084B (zh) * | 2017-11-21 | 2020-06-26 | 浙江迪福润丝生物科技有限公司 | 区分免疫和感染动物h5亚型禽流感疫苗株及其制备方法和应用 |
Family Cites Families (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3992522A (en) | 1973-01-24 | 1976-11-16 | The United States Of America As Represented By The Department Of Health, Education And Welfare | Temperature-sensitive recombinant mutant viruses and a process for producing same |
US4071618A (en) | 1974-09-03 | 1978-01-31 | Research Foundation For Microbial Diseases Of Osaka University | Process for preparing virus disease live vaccines |
JPS57136528A (en) | 1981-02-09 | 1982-08-23 | Hayashibara Biochem Lab Inc | Preparation of viral vaccine |
CH652145A5 (de) | 1982-01-22 | 1985-10-31 | Sandoz Ag | Verfahren zur in vitro-herstellung von hybridomen welche humane monoklonale antikoerper erzeugen. |
US4634666A (en) | 1984-01-06 | 1987-01-06 | The Board Of Trustees Of The Leland Stanford Junior University | Human-murine hybridoma fusion partner |
US4752473A (en) * | 1984-10-12 | 1988-06-21 | The Regents Of The University Of California | Expression of glycosylated human influenza hemagglutinin proteins |
US5202238A (en) | 1987-10-27 | 1993-04-13 | Oncogen | Production of chimeric antibodies by homologous recombination |
US6001634A (en) | 1989-08-28 | 1999-12-14 | Palese; Peter | Recombinant negative strand RNA viruses |
US5854037A (en) | 1989-08-28 | 1998-12-29 | The Mount Sinai School Of Medicine Of The City University Of New York | Recombinant negative strand RNA virus expression systems and vaccines |
US5840520A (en) | 1989-08-28 | 1998-11-24 | Aviron | Recombinant negative strand RNA virus expression systems |
US5166057A (en) | 1989-08-28 | 1992-11-24 | The Mount Sinai School Of Medicine Of The City University Of New York | Recombinant negative strand rna virus expression-systems |
US5665362A (en) | 1990-09-25 | 1997-09-09 | Cantab Pharmaceuticals Research Limited | Viral vaccines |
WO1993021306A1 (en) | 1992-04-14 | 1993-10-28 | The Mount Sinai School Of Medicine Of The City University Of New York | Genetically engineered attenuated viruses |
IL105456A (en) | 1992-04-21 | 1996-12-05 | American Home Prod | Vaccines of attenuated respiratory syncytial virus |
ES2210273T5 (es) | 1994-07-18 | 2010-03-29 | Conzelmann, Karl-Klaus, Prof. Dr. | Virus con arn de cadena negativa no segmentado recombinante infeccioso. |
US5716821A (en) | 1994-09-30 | 1998-02-10 | Uab Research Foundation | Prevention and treatment of respiratory tract disease |
WO1996010400A1 (en) | 1994-09-30 | 1996-04-11 | The Uab Research Foundation | Gene therapy vectors and vaccines based on non-segmented negatives stranded rna viruses |
US5756341A (en) | 1994-11-10 | 1998-05-26 | Immuno Ag | Method for controlling the infectivity of viruses |
US6146873A (en) | 1994-11-10 | 2000-11-14 | Baxter Aktiengesellschaft | Production of orthomyxoviruses in monkey kidney cells using protein-free media |
US7153510B1 (en) | 1995-05-04 | 2006-12-26 | Yale University | Recombinant vesiculoviruses and their uses |
US5690937A (en) | 1995-06-05 | 1997-11-25 | Aviron | Temperature sensitive clustered changed-to-alanine mutants of influenza virus PB2 gene |
DK0780475T4 (da) | 1995-08-09 | 2006-10-23 | Schweiz Serum & Impfinst | Fremgangsmåde til fremstilling af infektiöse negativ-streng RNA-virus |
WO1997012032A1 (en) | 1995-09-27 | 1997-04-03 | The Government Of The United States Of America, As Represented By The Department Of Health And Human Services | Production of infectious respiratory syncytial virus from cloned nucleotide sequences |
KR100754091B1 (ko) | 1995-10-31 | 2007-08-31 | 가부시끼가이샤 디나벡 겡뀨쇼 | 자율 복제 능력을 갖는 (-)쇄 rna 바이러스 벡터 |
WO1997016539A1 (fr) | 1995-11-01 | 1997-05-09 | Dnavec Research Inc. | Virus sendai recombinant |
US6090391A (en) | 1996-02-23 | 2000-07-18 | Aviron | Recombinant tryptophan mutants of influenza |
EP0912724B1 (en) | 1996-07-15 | 2009-12-09 | The Government of The United States of America, as represented by The Department of Health and Human Services | Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences |
AU4427897A (en) | 1996-09-27 | 1998-04-17 | American Cyanamid Company | 3' genomic promoter region and polymerase gene mutations responsible for att enuation in viruses of the order designated mononegavirales |
EP0994949B1 (en) | 1997-05-23 | 2011-03-09 | THE UNITED STATES OF AMERICA, as represented by the Secretary of the Department of Health and Human Services | Production of attenuated parainfluenza virus vaccines from cloned nucleotide sequences |
ES2287977T3 (es) | 1997-07-11 | 2007-12-16 | Yale University | Rabdovirus con cubiertas rediseñadas. |
WO1999015672A1 (en) | 1997-09-19 | 1999-04-01 | American Cyanamid Company | Attenuated respiratory syncytial viruses |
US6146642A (en) | 1998-09-14 | 2000-11-14 | Mount Sinai School Of Medicine, Of The City University Of New York | Recombinant new castle disease virus RNA expression systems and vaccines |
EP1035209A1 (en) | 1999-03-06 | 2000-09-13 | ARTEMIS Pharmaceuticals GmbH | Stable recombinant influenza viruses free of helper viruses |
KR100702275B1 (ko) | 1999-04-06 | 2007-03-30 | 위스콘신 얼럼나이 리서어치 화운데이션 | 백신 및 유전자 치료용 재조합 인플루엔자 바이러스 |
US8715940B2 (en) | 1999-04-06 | 2014-05-06 | Wisconsin Alumni Research Foundation | Method of making recombinant influenza virus |
WO2001064860A2 (en) | 2000-03-02 | 2001-09-07 | Polymun Scientific Immunbiologische Forschung Gmbh | Recombinant influenza a viruses |
ATE420189T1 (de) | 2000-04-28 | 2009-01-15 | St Jude Childrens Res Hospital | Dna-transfektionssystem zur erzeugung von infektiösen negativsträngigen rna virus |
KR100927517B1 (ko) | 2000-09-25 | 2009-11-17 | 폴리문 사이언티픽 임무노이비오로기쉐 포르슝 게엠베하 | 생균 백신 |
USPP15035P3 (en) * | 2001-06-27 | 2004-07-27 | Marko Zaninovich, Inc. | Grapevine ‘12-76-71’ |
KR100600988B1 (ko) * | 2002-03-13 | 2006-07-13 | 주식회사 엘지생명과학 | Dna 면역화에서 인플루엔자 np 유전자 dna를 함께투여하여 면역반응을 증가시키는 방법 |
US7465456B2 (en) | 2002-04-26 | 2008-12-16 | Medimmune, Llc | Multi plasmid system for the production of influenza virus |
KR101229202B1 (ko) | 2002-04-26 | 2013-02-01 | 메디뮨 엘엘씨 | 인플루엔자 바이러스의 생산을 위한 다중 플라스미드 시스템 |
EP2581093B1 (en) | 2003-06-16 | 2015-03-18 | MedImmune, LLC | Influenza hemagglutinin and neuraminidase variants |
US7037707B2 (en) | 2003-09-04 | 2006-05-02 | St. Jude Children's Research Hospital | Method for generating influenza viruses and vaccines |
ES2525672T3 (es) | 2004-05-25 | 2014-12-29 | Medimmune, Llc | Variantes de la hemaglutinina y la neuraminidasa de influenza |
EP1826269B1 (en) | 2004-11-01 | 2012-04-04 | Eiken Kagaku Kabushiki Kaisha | Method of detecting h5 avian influenza virus |
EP1856271A4 (en) | 2005-03-08 | 2009-11-18 | Medimmune Vaccines Inc | INFLUENZA HEMAGGLUTININE AND NEURAMINIDASE VARIANTS |
RU2315101C2 (ru) * | 2006-01-10 | 2008-01-20 | ГУ "Научно-исследовательский институт экспериментальной медицины "Российской Академии медицинских наук (ГУ НИИЭМ РАМН) | Вакцинный штамм вируса гриппа а/17/калифорния/ 04/6 (н3n2) и донор аттенуации а/ленинград/134/17/к7/57 (н2n2) для его получения |
JP2010500034A (ja) | 2006-08-09 | 2010-01-07 | メッドイミューン バクシーンズ,インコーポレイティド | インフルエンザ赤血球凝集素変異体およびノイラミニダーゼ変異体 |
WO2009014919A2 (en) * | 2007-07-13 | 2009-01-29 | Iowa State University Research Foundation, Inc. | H2n3 influenza a viruses and methods of use |
BRPI1008549A2 (pt) | 2009-02-12 | 2016-03-15 | Medimmune Llc | variantes de neuraminidase e hemaglutinina de influenza |
-
2010
- 2010-02-03 BR BRPI1008549A patent/BRPI1008549A2/pt not_active IP Right Cessation
- 2010-02-03 CA CA 2752205 patent/CA2752205A1/en not_active Abandoned
- 2010-02-03 JP JP2011550155A patent/JP5818693B2/ja not_active Expired - Fee Related
- 2010-02-03 MX MX2011008497A patent/MX2011008497A/es active IP Right Grant
- 2010-02-03 SG SG2011057791A patent/SG173642A1/en unknown
- 2010-02-03 EP EP10741567.1A patent/EP2396033B1/en not_active Not-in-force
- 2010-02-03 RU RU2011137404/10A patent/RU2535970C2/ru not_active IP Right Cessation
- 2010-02-03 AU AU2010213966A patent/AU2010213966B2/en not_active Ceased
- 2010-02-03 CN CN2010800138806A patent/CN102361649A/zh active Pending
- 2010-02-03 SG SG2014010185A patent/SG2014010185A/en unknown
- 2010-02-03 US US12/699,108 patent/US8613935B2/en not_active Expired - Fee Related
- 2010-02-03 WO PCT/US2010/022970 patent/WO2010093537A2/en active Application Filing
-
2011
- 2011-08-11 MX MX2013015094A patent/MX343411B/es unknown
-
2013
- 2013-11-21 US US14/086,902 patent/US9119812B2/en not_active Expired - Fee Related
-
2014
- 2014-10-08 RU RU2014140731A patent/RU2014140731A/ru not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2752205A1 (en) | 2010-08-19 |
JP5818693B2 (ja) | 2015-11-18 |
RU2011137404A (ru) | 2013-03-20 |
EP2396033A4 (en) | 2013-10-23 |
WO2010093537A3 (en) | 2010-10-07 |
EP2396033A2 (en) | 2011-12-21 |
RU2014140731A (ru) | 2016-04-27 |
MX343411B (es) | 2016-11-04 |
RU2535970C2 (ru) | 2014-12-20 |
SG173642A1 (en) | 2011-09-29 |
BRPI1008549A2 (pt) | 2016-03-15 |
US8613935B2 (en) | 2013-12-24 |
WO2010093537A2 (en) | 2010-08-19 |
AU2010213966B2 (en) | 2015-01-22 |
AU2010213966A1 (en) | 2011-09-01 |
SG2014010185A (en) | 2014-06-27 |
US9119812B2 (en) | 2015-09-01 |
US20100330118A1 (en) | 2010-12-30 |
US20140079726A1 (en) | 2014-03-20 |
CN102361649A (zh) | 2012-02-22 |
JP2012517239A (ja) | 2012-08-02 |
EP2396033B1 (en) | 2016-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2011000437A (es) | Variantes de hemaglutinina y neuramnidasa de influenza. | |
MX2012000123A (es) | Variantes de hemaglutinina de la influenza porcina. | |
IL231547B (en) | Polypeptide of the chimeric hemagglutinin (ha) from an influenza virus, an immune composition containing it and its uses | |
WO2008021959A3 (en) | Influenza hemagglutinin and neuraminidase variants | |
MX2021001053A (es) | Vacunas contra virus de la influenza y sus usos. | |
WO2006098901A3 (en) | Influenza hemagglutinin and neuraminidase variants | |
IL210215A0 (en) | Influenza virus-like particles (vlps) comprising hemagglutinin | |
WO2012024621A3 (en) | Synthetic nanocarrier vaccines comprising peptides obtained or derived from human influenza a virus hemagglutinin | |
WO2005116260A3 (en) | Influenza hemagglutinin and neuraminidase variants | |
PH12015501482B1 (en) | Nasal influenza vaccine composition | |
WO2011103453A3 (en) | Vaccines for use in the prophylaxis and treatment of influenza virus disease | |
MX2010008799A (es) | Proceso para estabilizar una composicion de vacuna que contiene adyuvante. | |
EP2552479A4 (en) | INFLUENZA VIRUS VACCINES AND USES THEREOF | |
WO2008112017A3 (en) | Avian influenza vaccine | |
AP2008004625A0 (en) | Avian influenza viruses, vaccines, compositions, formulations, and methods | |
IL200588A0 (en) | Lyophilized preparation comprising influenza vaccine, and method for preparation thereof | |
IL224022B (en) | Thermally stable influenza vaccine | |
NZ606087A (en) | Influenza vaccine | |
EA201290897A1 (ru) | Вакцины для пандемического гриппа | |
MX343411B (es) | Variantes de hemaglutinina y neuraminidasa de influenza. | |
ZA200809056B (en) | Influenza virus vaccine | |
EP2117589A4 (en) | FLAVIVIRUS VACCINE VECTOR AGAINST INFLUENZA VIRUS | |
EP2716752A4 (en) | RECOMBINANT DOG INFLUENZA VIRUS, MANUFACTURING METHOD AND APPLICATION THEREOF | |
EP2640405A4 (en) | TREATMENT AND / OR CHARACTERIZATION OF INFLUENZA; POLYPEPTIDES HA ADAPTED TO MAN | |
AP2013006835A0 (en) | Novel vaccines against the A/H1N1 pandemic flu virus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |